// App-Quantinova.ai

O22 : Frequency and reasons for switching back to etanercept originator following initial switch to etanercept biosimilar

Researchers

Presenter

  • Rebecca Davies

Principal Investigators

  • Lianne Kearsley-Fleet

  • Mark Lunt

  • Kath D Watson

  • Kimme L Hyrich

Medical Centers

  • Arthritis Research UK Epidemiology Unit, The University of Manchester, Manchester, UK

  • National Institute of Health Research Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Etanercept biosimilar

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved